| Patent Number |
Title Of Patent |
Date Issued |
| RE37270 |
Liquid crystal phase |
July 10, 2001 |
| Liquid crystal phases containing components of the formulae I and III ##STR1##have an acceptable combination of threshold steepness, viewing angle and temperature dependence at a low threshold voltage. |
| 8236804 |
Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine |
August 7, 2012 |
| The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine |
| 8193195 |
Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hy |
June 5, 2012 |
| The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine |
| 7981894 |
Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hyd |
July 19, 2011 |
| The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine, crystaline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine and am |
| 7955664 |
Chroman compounds |
June 7, 2011 |
| The chroman compounds of the formula I according to the invention R.sup.1-(A.sup.1-Z.sup.1).sub.a--W.sup.1--(Z.sup.2-A.sup.2).sub.b-Z.sup.3- --W.sup.2--(Z.sup.4-A.sup.3).sub.c-R.sup.2 in which R.sup.1, A.sup.1, A.sup.2, A.sup.3, W.sup.1, W.sup.2, Z.sup.1, Z.sup.2, Z.sup.3, Z.sup.4, a |
| 7888519 |
Pyran compound or at least one derivative thereof |
February 15, 2011 |
| The invention relates to pyran derivatives of the formula I ##STR00001## and to a process and intermediates for their preparation and derivatisation, and to the use thereof in liquid-crystalline media. |
| 7872039 |
3-aminoindazoles |
January 18, 2011 |
| Novel 3-aminoindazoles of the formula (I) are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, general |
| 7858376 |
Ninhydrin and ionic liquid reagent mixture and method for the visualization of amino acids and p |
December 28, 2010 |
| The invention relates to a method and reagent mixture for the staining and thus visualization of amino acids, peptides and similar compounds, in particular after separation by means of thin-layer chromatography. The staining is carried out using ninhydrin for the detection of amino acids |
| 7834020 |
Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine |
November 16, 2010 |
| The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine |
| 7829658 |
Mono-, oligo- and polymers of thienothiazole |
November 9, 2010 |
| The invention relates to novel mono-, oligo- and polymeric compounds comprising thienothiazole groups, to their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices, and to optical, electro-optical or electronic devices comprising the |
| 7807236 |
Liquid-crystalline medium |
October 5, 2010 |
| The invention relates to a liquid-crystalline medium, characterised in that it comprises one or more compounds of the formula I ##STR00001## in which R.sup.0, L.sup.1, n, A and B have the meanings indicated in Claim 1, furthermore to novel compounds of the formula I, to processes for th |
| 7807068 |
Polymerizable compounds |
October 5, 2010 |
| The present invention relates to novel polymerizable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displa |
| 7691456 |
Spiro[3.3] heptyl-dioxan derivatives and their use in liquid crystal media |
April 6, 2010 |
| The invention relates to novel dioxane derivatives of the formula R.sup.1-(A.sup.1-Z.sup.1).sub.m-G-(Z.sup.2-A.sup.2).sub.n-R.sup.2, in which G denotes (I) or (II), and in which R.sup.1, R.sup.2, A.sup.1, A.sup.2, Z.sup.1, Z.sup.2, m and n have the meanings indicated in claim 1, to t |
| 7658978 |
Liquid crystalline medium |
February 9, 2010 |
| The invention relates to a liquid crystalline medium containing one or more compounds of formula I, wherein R.sup.1 and R.sup.2 have the meanings described in claim 1, to its use for electrooptical purposes, and to displays containing this medium. ##STR00001## |
| 7656490 |
LC display device with parallel field component |
February 2, 2010 |
| An electro-optical display device comprising a liquid crystal layer achieves switching using an electric field component which is predominantly parallel to the surface of the liquid crystal layer. Low dependence of image contrast on viewing angle is achieved by selection of parameter |
| 7648646 |
LC material with homeotropic alignment |
January 19, 2010 |
| The invention relates to a liquid crystal (LC) material that aligns homeotropically on substrates with high or low surface energy. |
| 7629257 |
Combined etching and doping substances |
December 8, 2009 |
| The invention concerns etching and doping substances free of hydrochloric/fluoride acid used for etching inorganic layers as well as for doping subjacent layers. The invention also concerns a method wherein said substances are used. |
| 7618988 |
Use of substituted aminomethyl chromans |
November 17, 2009 |
| Compounds of formula I in which R has a meaning as indicated in claim 1, or one of their optical isomers or pharmaceutically acceptable salts, used for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders and/or for the treatm |
| 7582656 |
Guanidine derivatives and therapeutic uses thereof |
September 1, 2009 |
| Compounds of the formula (I): ##STR00001## in which the radicals R and R.sup.1 to R.sup.10 are as defined in the description,processes for the preparation of them,use thereof for the treatment of cardiovascular diseases, andpharmaceutical compositions comprising them. |
| 7534785 |
3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives |
May 19, 2009 |
| Compounds of the formula I, in which R1, R2, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours. ##STR00001## |
| 7329749 |
Piperazinylcarbonylquinolines and -isoquinolines |
February 12, 2008 |
| Compound of the formula (I) in which R.sup.1, R.sup.2 and alk are as defined in Claim 1, are potent 5-HT.sub.2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sc |
| 7285681 |
Biguanide derivatives |
October 23, 2007 |
| The present invention relates to biguanide derivatives of formula (I), wherein R1, R2, R3 and R4 have the meanings as given in claim (1). Compounds are useful in the treatment of pathologies associated with hyperglycaemia, such as diabetes. ##STR00001## |
| 7271302 |
Method for brominating organic compounds |
September 18, 2007 |
| The present invention relates to processes for the bromination of organic compounds, and to bromination microreactors for carrying out these processes. |
| 7264795 |
Sunscreen composition |
September 4, 2007 |
| The present invention relates to a composition having UV protection properties, charaterized in that the formulation comprises at least one encapsulated organic sunscreen and does not penetrate the skin essentially. |
| 7264670 |
Coloured microstructured effect pigments |
September 4, 2007 |
| Disclosed are colored flake-form effect pigments comprising one or more layers, where at least one of the layers comprises one or more colorants or is itself a colorant and at least one of the layers has a groove or grid structure, and to processes for the preparation thereof, and to the |
| 7262216 |
Benzofuran compounds and their use as antidepressants and anxiolytics |
August 28, 2007 |
| Novel benzofuran derivatives of the formula (I) in which R.sup.1, R.sup.2, X, Y, Z and m have the meanings indicated in Patent Claim 1, they have a strong affinity to the 5-HT.sub.1A receptors. The compounds inhibit serotonin reuptake, exhibit serotonin-agonistic and -antagonistic pr |
| 7241502 |
Moulded bodies consisting of core-shell particles |
July 10, 2007 |
| The invention relates to mouldings having an optical effect which essentially consist of core/shell particles whose shell forms a matrix and whose core is essentially solid and has an essentially monodisperse size distribution, where a difference exists between the refractive indices |
| 7238757 |
Oxygen-containing organoaluminium complexes as cocatalysts |
July 3, 2007 |
| Disclosed are compounds of formula (I) ##STR00001## which compounds are useful as cocatalysts in olefinic polymerisation reactions, e.g., as Ziegler-Natta catalysts. |
| 7220464 |
Nematic liquid-crystal mixture, and displays containing same |
May 22, 2007 |
| A nematic liquid-crystal mixture contains a compound of formula I ##STR00001## in which R.sup.11 and R.sup.12 are as defined in the specification, and a liquid-crystal displays containing same. |
| 7208626 |
Method for the production of perfluoroalkyl phosphines and the use thereof as perfluoroalkylatin |
April 24, 2007 |
| The invention relates to a method for producing perfluoroalkyl phosphines, comprising at least one step in which at least one fluoro(perfluoroalkyl)phosphorane is reacted with at least one hydride ion donator, and the use of tris(perfluoroalkyl)phos-phines as perfluoroalkylating reac |
| 7199133 |
Derivatives of phenoxy-n-'4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and oth |
April 3, 2007 |
| Novel compounds of formula (I), wherein D, W, X, Y, T and R.sup.1 have the meanings cited in claim 1, are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors ##STR00001## |
| 7198828 |
Liquid-crystalline medium |
April 3, 2007 |
| The invention relates to a liquid-crystalline medium which is characterized in that it comprises one or more compounds of the formula A ##STR00001## and at least one compound of the formula B ##STR00002## in which R.sup.a, R.sup.b, Y, Z.sup.1, Z.sup.2, L.sup.1, L.sup.2, L.sup.3, L. |
| 7186358 |
Polymer dopants |
March 6, 2007 |
| A polymer dopant for electrially conducting, photoconducting and semiconducting components and devices and novel polymers comprising electron accepting groups that are suitable as polymer dopants. |
| 7183418 |
Mono-, oligo- and polythieno[2,3-b]thiophenes |
February 27, 2007 |
| The invention relates to novel mono-, oligo and poly[2,3-b]-thienothiophenes, their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices like for example liquid crystal displays, optical films, organic field effect transistors (FET or |
| 7166720 |
Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides |
January 23, 2007 |
| Hydroxy-imino derivatives of formula IIb are disclosed, ##STR00001## in which R and R.sup.1 have the meanings given in the description. |
| 7153550 |
Liquid crystalline medium and liquid crystal display |
December 26, 2006 |
| The instant invention relates to liquid crystalline media comprising a dielectrically positive component, component A, consisting of dielectrically positive compounds, comprising one or more compounds of formula I and one or more compounds of formula II ##STR00001## wherein the para |
| 7145004 |
Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates and per |
December 5, 2006 |
| The present invention relates to a process for the preparation of monohydroperfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates which comprises at least the treatment of at least one perfluoroalkylphosphorane with at least one base in a suitable reaction m |
| 7141572 |
Hydrazono-malonitriles |
November 28, 2006 |
| Hydrazono-malonitrile derivatives of the formula (I) in which R.sup.1, R.sup.2, R.sup.3, R.sup.3' and R.sup.4 have the meanings given in Claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid |
| 7129241 |
Pyridazine derivatives |
October 31, 2006 |
| Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmu |
| 7122227 |
Chiral photoisomerizable compounds |
October 17, 2006 |
| The invention relates to chiral photoisomerizable compounds of formula (I) wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5 and X.sup.6 have the meanings given in claim 1, to liquid crystalline mixtures and polymers containing them, and to the use of chiral photoisomerizable compounds |
| 7105708 |
Method for producing compounds having a CF.sub.2O bridge |
September 12, 2006 |
| The invention relates to a process for the preparation of compounds containing at least one --CF.sub.2--O-- bridge in the molecule, in which a) an acid is added onto at least one ketene dithioketal, b) the resultant bis(alkylthio)carbenium salt is reacted with at least one compound h |
| 7101537 |
Tricyclic quinoxaline and quinoline derivatives as a UV filter |
September 5, 2006 |
| The invention relates to the use of quinoxaline derivatives of formula I, represented by formulas 1a and 1b, as photostable UV filters, in particular in cosmetic and pharmaceutical preparations for protecting the human epidermis or human hair against UV radiation, above all in the 280 |
| 7060774 |
Prepolymer material, polymer material, imprinting process and their use |
June 13, 2006 |
| The invention relates to a prepolymer material based on monomeric, oligomeric or polymeric compounds with at least one ethylenically unsaturated (meth)acryloyl group. The problem of imperfect imprinting properties, escpecially of an unwanted adhering to the imprinting stamp or mold, |
| 6998254 |
Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis |
February 14, 2006 |
| The subject of the present invention is the use of the ROR receptors and/or of their response element or alternatively of a functional equivalent thereof for the screening of substances having antiatherosclerotic properties. The invention also relates to the methods of screening subs |
| 6995241 |
Splice variant of head trauma induced cytoplasmatic calcium binding protein |
February 7, 2006 |
| ANIC-BP-1B polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ANIC-BP-1B polypeptides and polynucleotides in diagnostic assays. |
| 6812015 |
Histidine protein-phosphatase |
November 2, 2004 |
| The invention relates to a novel enzyme, histidine protein phosphatase, which is derived from mammalian sources, and its homologue variants. The invention further relates to DNA sequences encoding said proteins, to a process for preparing the latter, and to antibodies directed against th |
| 6800338 |
Electro-optical liquid-crystal display |
October 5, 2004 |
| To provide an electro-optical liquid-crystal displays with low addressing voltages and low to moderate multiplex ratios, in particular STN displays, organic alignment layers of low layer thickness are utilized. |
| 6730314 |
Culturing encapsulated chondrocytes under reduced oxygen partial pressure to produce cartilage i |
May 4, 2004 |
| A process is provided for the production of a human cartilage implant from chondrocytes cultured in vitro, which come as close as possible to the original with respect to their biochemical composition and biomechanical properties. Up to 20% vol. of human serum is used as medium addition |
| 6726856 |
Process for preparing electrically conductive pigments |
April 27, 2004 |
| The invention relates to a process for preparing electrically conductive pigments based on F.sup.- - and/or PO.sub.4.sup.3- -doped tin mixed oxides applied as an electrically conductive layer to a substrate, in which, first of all, SnO.sub.2 -coated substrates are prepared by precipitati |
| 6689205 |
Multilayer interference pigments |
February 10, 2004 |
| Multilayer interference pigment consisting of a transparent carrier material coated with alternating layers of metal oxides of low and high refractive index, the difference in the refractive indices being at least 0.1, which is obtainable by alternate coating of the transparent carrier |
